Using health insurance claims, we identified common first-, second-, and third-line chemotherapy regimens for patients with lung cancer and associated utilization and costs of care.
Lauri S. Tock, MHA
Advertisement
Articles by Lauri S. Tock, MHA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Judge Denies Preliminary Injunction in Medicaid Work Requirements Case
2
FDA Panel Backs 6 Peptides for Compounding
3
AHRQ Grant Freeze Halts Patient Safety Research Nationwide
4
FDA Advisory Panel Votes Against Approval of Deramiocel for DMD
5